Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
Clinical trial NCT02609022 · COMPLETED
Trial details
- NCT number
- NCT02609022
- Sponsor
- CuraVac
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-09-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.